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Background: Colorectal cancers are the third most common type in the world. The causes of the disease are
poorly understood, but since the discovery of Helicobacter pylori as a causative agent of gastric cancer, attention
has turned to bacteria as a possible trigger for colorectal cancer. Recently H. pylori outer membrane vesicles (OMVs)
were revealed as potentially genotoxic which can be important first step in carcinogenesis. We therefore
investigated whether OMVs from intestinal Escherichia coli could be genotoxic.
Methods: OMVs from the avirulent DH5α strain, a pathogenic adherent-invasive E. coli (AIEC) and an enterohaemolytic
(EHEC) strain of E. coli were enriched by ultracentrifugation. The effect on the growth and viability of human
enterocyte-like Caco-2 cells by OMVs was determined by trypan blue exclusion, MTT and BrdU incorporation assays.
The ability of OMVs to induce DNA damage was assayed by single-cell gel electrophoresis, and 8-oxo-dG and γH2Ax
immunofluorescence staining. Cytopathological changes were assessed by microscopy. The induction of aneuploidy
by the OMVs was measured by flow cytometry in Caco-2 and LoVo cells.
Results: We found that OMVs derived were internalised by Caco-2 cells, increased cell numbers, induced
double-stranded DNA breaks, recruited γH2Ax to the nucleus, initiated DNA rereplication, and produced distended
multinucleate cells. DH5α and AIEC OMVs caused free radical generation as indicated by the reduction of glutathione
in cells, leading to the development of mutagenic 8-oxo-dG adducts in DNA. Flow cytometry revealed that DH5α
and EHEC OMVs increased aneuploidy in p53 mutant Caco-2 cells, but not in p53 wild type LoVo cells.
Conclusion: We conclude that E. coli derived OMVs, whether from avirulent or pathogenic strains are
potentially genotoxic.
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Colorectal cancer is a significant cause of morbidity and
mortality. It is the third most common cancer diagnosed
amongst men and the second amongst women (663 000
and 571 000 cases each year, respectively) [1] and is par-
ticularly prevalent in Western countries, with the highest
incidence in Australasia [2]. The genesis of colorectal
cancer is poorly understood, but chromosomal instability
is a characteristic of many sporadic colon cancers. The fea-
tures of chromosomal instability include DNA damage,
and failure of DNA repair, leading to aneuploidy [3].
A number of risk factors have been identified, including,
but not restricted to, age, a history of inflammatory bowel* Correspondence: peter.tyrer@otago.ac.nz
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reproduction in any medium, provided the ordisease, a family history of colorectal cancer, obesity, smok-
ing [4,5] and alcohol use [6]. Recently, it has been proposed
that intestinal bacteria, including commensals as well as
pathogens, may also play a role in the aetiology of this dis-
ease [7-10]. Bacteria were first identified as a cause of can-
cer when Helicobacter pylori was shown to be involved in
the development of gastric cancer [11]. Inevitably, this has
led to the hypothesis that other bacteria may also initiate
carcinogenesis, particularly those strains that produce
toxins [12,13]. Moreover, there is mounting evidence that
bacteria do not need to be invasive to affect this response.
Gram-negative bacteria constitutively release outer mem-
brane vesicles (OMVs), both in vivo and in vitro. These
50-200 nm diameter proteoliposomes consist of outer
membrane and periplasmic proteins [14], lipopolysac-
charide, peptidoglycans, and may contain DNA and RNAd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of virulence genes that include toxins and/or molecules
that assist in the attachment to and invasion of target
host cells [16-23]. Thus, OMVs may act as long range ef-
fectors to remotely deliver toxins to host cells [24] and
provide a further virulence mechanism in addition to, for
example, Type IV secretion systems. We recently de-
scribed that vesicles shed from the surface of a toxin-
producing strain of H. pylori are rapidly internalised by
human gastric carcinoma AGS cells [25] alter prolifera-
tion and induce oxidative stress, leading to genotoxicity
that could result in chromosomal instability [26].
Escherichia coli are commonly found within the hu-
man intestinal tract. Indeed, most E. coli strains are part
of the normal microflora of the gut where they contrib-
ute to food digestion. In addition, commensal strains of
E. coli are thought to compete with potential pathogens
(for example by the production of bacteriocins), so inhi-
biting infection [27]. In contrast, some species of E. coli
produce toxins. Whereas these toxins cause diarrheal
diseases that can lead to significant illnesses and death
[28], their role as potential carcinogens is less well under-
stood. Given the genotoxicity of H. pylori OMVs, we
hypothesised that E. coli OMVs might also induce DNA
damage and aneuploidy.
We used the human adenocarcinoma-derived cell line
Caco-2 as a model of gut enterocytes and exposed these
cells to OMVs constitutively expressed by three strains
of E. coli that included an avirulent strain [29], an
adherent-invasive E. coli (AIEC) strain associated with
inflammatory bowel disease and colon cancer [30] and a
Shiga toxin (STx)-producing, enterohaemolytic (EHEC)
O157:H7 strain associated with bloody diarrheal disease
and haemolytic uremic syndrome (HUS) [31]. We exam-
ined whether these OMVs were internalised by Caco-2
cells and investigated the effect that the OMVs from
each of these three different strains of E. coli had on
cell proliferation and viability. The ability of the OMVs
to induce abnormal cell morphology, oxidative stress,
damage DNA, and produce aneuploid cells was also
assessed.Figure 1 Electron micrographs of preparations of outer membrane ve
bacteria in LB broth. OMVs are indicated by black arrows. Magnification 93Results
OMVs are internalised by Caco-2 cells
E. coli grown in broth have been shown to constitutively
shed OMV [32]. OMVs can be enriched by ultracentrifu-
gation with no biologically active contaminants [25]. We
observed that all three strains of E. coli used in this
study constitutively shed OMVs and these were numer-
ous in each preparation when examined by TEM. The
enriched OMVs ranged in size between 25-200 nm in
diameter (arrowed in Figure 1) and these dimensions agree
with previously published reports [33]. We have previously
shown that in enriched OMVs preparations contaminants,
such as flagella, are at least partially depleted [23,34] and in
this study TEM did not reveal significant quantities of
these impurities in our OMV preparations from any of the
E. coli strains we used. Using immunofluorescence micros-
copy, we then determined if the OMVs produced by three
E. coli strains used in this study are internalised by Caco-2
cells [20]. By labelling OMVs with the fluorescent,
membrane-intercalating dye 3,3′-dioctadecyloxacarbocya-
nine perchlorate (DiO) we were able to show that vesicles
entered the cells, irrespective of whether they were from
attenuated laboratory or pathogenic strains of E coli. More-
over, orthogonal views reconstructed from image slices
0.28 μm apart, confirmed that the OMVs were located in
the perinuclear regions of cells (Figure 2).
OH157:H7 OMVs induce growth of Caco-2 cells, but viability
is unaffected
Carcinogenesis is characterised by the dysregulation of
cell proliferation, resulting in uncontrolled cell growth
[35], and we hypothesised that E. coli OMVs might in-
crease the growth of Caco-2 cells. In dose response experi-
ments, we determined that doses of OMVs between 0.005
and 5 μg/ml had no significant effect on the growth
(Figure 3A) or viability of Caco-2 cells (Figure 3B) over
168 hours. We then monitored the effect that 5 μg/ml
OMVs had on cell numbers in kinetic studies by exposing
the cells to OMVs for up to 168 hours and conducting try-
pan blue exclusion assays every second day of culture. We
observed that unstimulated control cells continued tosicles. E. coli OMVs were recovered following the overnight growth of
000. Size bar indicates 200 nm.
Figure 2 E. coli OMVs are internalised by and localise to the perinuclear regions of Caco-2 cells. Fluorescent DiO–labelled OMVs (green),
were added to Caco-2 cells for 4 hours before the cells were stained for actin (red) and nuclei (blue). Image stacks were taken 0.28 μm apart. The top
images represent a maximum intensity z-projection constructed in ImageJ whereas the bottom images are insets of those above with their x-z
and y-z orthogonal projections to show that OMVs are internalised by Caco-2 cells. Images are from a single representative experiment. Original
magnification = 40×, NA1.3 objective used. Note that the figure for O157:H7 OMV treated Caco-2 cells shows an enlarged, intoxicated nucleus.
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growth began to decline slightly, as expected, as they
reached confluence. Cells stimulated with OMVs derived
from E. coli strain DH5α also continued to grow through-
out the period of the experiment, but there was no sig-
nificant difference in growth at any time point when the
results were normalised to the untreated control cells
(Figure 3C). In contrast, exposure to OMVs from the
other two strains of E. coli accelerated the Caco-2 cell
growth. For LF82 OMVs, these increases were statistically
significant after 72 and again at 120 hours, (122% +/- 6,
p = 0.021 and 117% +/- 2, p = 0.001, respectively, com-
pared to control) but cell numbers declined thereafter. In
the case of O157:H7 OMVs, cells numbers were signifi-
cantly increased after 72 hours (111% +/- 4, p = 0.036) and
remained increased at 168 hours (131% +/- 10, p = 0.039)
when compared to untreated control cells (Figure 3C). In
contrast, the E. coli OMVs had no significant cytotoxic
affect on the Caco-2 cells over time (Figure 3D). Together,
these results indicate that DH5α OMVs have no significant
effect on cell growth. This is not surprising in the case of
DH5α, which is considered to be avirulent and non-
pathogenic [29]. Strain LF82 transiently increased cell
growth over time and had no effect on cell cytotoxicity,
as reported elsewhere [36]. OMVs derived from the
more pathogenic O157:H7 strain also had no significant
cytotoxic effect on Caco-2 cells. However, these OMVs
were associated with a significant increase in cell growth
over time, and this growth continued even when unstimu-
lated control cells had reached confluence. These data
indicate that LF 82 and O157:H7 OMVs can dysregulate
cell growth.In addition to using trypan blue to determine cell
number and viability, we also used the (3-(4,5-Dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) [37]
(Figure 3E) and 5-bromo-2′-deoxyuridine (BrdU) in-
corporation [38] (Figure 3F) assays, which are common
high-throughput means to determine cell proliferation. In-
triguingly, both assays produced results that were contrary
to those obtained by use of the trypan blue exclusion
assay. In the case of the MTT determinations (which in-
fers viable cell numbers from the reduction of MTT),
there was an approximately 20% increase in MTT reduc-
tion above that of controls at lower doses, that then de-
creased with increasing OMV concentration.
The difference between viable cell counts and the re-
sults of the BrdU incorporation assays was even more
marked, with the incorporation of BrdU in OMV-treated
cells measured as up to 400% of control values.
OMVs induce glutathione reduction in Caco-2 cells
The MTT assay is used as a technique to determine cell
viability, however it does so by proxy by relying on the
reduction of tetrazolium dye to formazan by NAD(P)H-
dependent cellular oxidoreductase enzymes. Thus, any
agent that affects the expression or activity of these en-
zymes can affect the assay. For example metabolic un-
couplers [39,40] can falsely give rise to increased cell
counts measured by this assay. Furthermore, tetrazolium
can be reduced by a variety of agents without increasing
cell viability, including genistein [41], ursolic acid [42],
resveratrol [43], and interferons [44]. The discrepant data
obtained from the MTT assay could also be due to mito-
chondrial dysfunction, and a consequence of this is the
Figure 3 (See legend on next page.)
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Figure 3 E. coli OMVs increase Caco-2 cell proliferation. (A) Dose dependent proliferation indices and (B) percentage cytotoxicity of Caco-2
cultures after 7 days exposure to OMVs, determined by trypan blue assay. (C) Time dependent proliferation indices and (D) percentage cytotoxicity of
Caco-2 cultures after 7 days exposure to OMVs, determined by trypan blue assay. (E) OMVs increase MTT reduction by Caco-2 cells. (F) OMVs increase the
synthesis of DNA in Caco-2 cells as determined by BrdU incorporation assay. *, results are significantly different from untreated controls (p≤ 0.05). ANOVA,
followed by two-sided Dunnet’s post hoc test. Results are ± SEM of three independent experiments. In c, e and f, the line denotes 100% i.e. unexposed
control values.
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hypothesised that E. coli OMVs might increase the gener-
ation of ROS in Caco-2 cells. There is an inverse correl-
ation between oxidative stress and cellular glutathione
(GSH) levels [46]. H. pylori OMVs have been shown to re-
duce the presence of GSH in AGS cells [26]. Accordingly,
we determined the effect of E. coli OMVs on cellular GSH
levels (Figure 4A).
The level of GSH in unstimulated Caco-2 cells was
1.4+/-0.7 nM whereas exposure to 200 μM hydrogen
peroxide (a positive control to induce oxidative stress)
for 24 hours reduced cellular GSH levels to below the
limit of detection of the assay. Exposure to OMVs from
E. coli strains LF82 or DH5α also had a significant effect
on cellular GSH levels, again reducing them to below the
limit of detection. In contrast, O157:H7 OMVs added to
Caco-2 cells had no significant effect on cellular GSH
levels when compared to unstimulated controls (Figure 4A),
suggesting that OMVs from some but not all strains of
E. coli have the potential to induce oxidative stress in gut
epithelial cells.
OMVs generate DNA damage in Caco-2 cells
The generation of ROS can lead to DNA damage [47,48]
and the formation of mutagenic DNA adducts that in-
clude 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxo-dG)
[49]. Thus, we hypothesised that we would find evidence
of 8-oxo-dG adducts within the nuclei of Caco-2 cells
exposed to OMVs. Immunofluorescence microscopy was
used to demonstrate that OMV exposed cells have in-
creased staining for 8-oxo-dG, indicating a level of oxi-
dative DNA damage not observed in untreated cells.
These results suggest that OMVs from a non-pathogenic
as well as a pathogenic strain of E. coli (DH5α and LF82,
respectively) are capable of inducing mutagenic changes
to genomic DNA with the potential to lead later to the
initiation of carcinogenesis. In contrast, Caco-2 cells ex-
posed to OMVs from E. coli strain O157:H7 did not dis-
play higher levels of 8-oxo-dG labelling (Figure 4B). This
would indicate that vesicles from this strain of E. coli do
not induce these adducts in Caco-2 cells, a finding that
is consistent with the lack of oxidative stress in these
cells following exposure O157:H7 OMV.
Free radicals, as well as some bacterial toxins that in-
clude the cytolethal distending toxin that is expressed by
E. coli O157:H7 and found in their OMVs [50], canproduce double stranded breaks (DSBs) in DNA [50,51].
Single-cell gel electrophoresis is a powerful technique to
quantitate this damage. All three of the OMVs tested in-
duced increases in DSBs with a peak at 0.05 μg/ml
OMV for DH5α (13.42% +/- 0.92 DNA in tail, p = 0.001)
and LF82 (16.48% +/- 4.29 DNA in tail, p = 0.013) that
declined at higher doses compared to control (4.48% +/-
0.77 DNA in tail). In contrast there were significant in-
creases in damage at 0.05 and 5 μg/ml O157:H7 OMVs
(16.91% +/- 2.27, p = 0.005 and 17.68 +/- 3.27, p = 0.003
DNA in tail, respectively) (Figure 4C). DNA damage was
also evident in Caco-2 cells exposed to 300 μM H2O2
for 24 hours (15.09% +/- 3.56 DNA in tail). Collectively,
these results show that OMVs can induce DNA damage
in Caco-2 cells. It is possible to speculate that he bell-
shaped dose-response curves caused by DH5α and LF82
may indicate that the causes of DNA damage in response
to these OMVs may be quite complex, perhaps due the in-
duction of anti-oxidant pathways (e.g. Nrf-2) at higher
doses, but this remains to be determined.
E. coli OMVs induce DNA synthesis and repair in
Caco-2 cells
DNA damage induces DNA synthesis and repair mecha-
nisms and the large increases in BrdU incorporation de-
scribed above provide some evidence for this in OMV
exposed Caco-2 cells. The BrdU assay measures the in-
corporation of a thymidine analogue into DNA during
the S-phase of the cell cycle [38]. Accordingly, this tech-
nique measures the number of actively dividing cells.
However, DNA synthesis and hence BrdU incorporation,
can be initiated by DNA damage, followed by repair in
response to genotoxic agents [52,53]. Thus, it appears
that the large increases in DNA incorporation induced
by the E. coli OMVs could be due to DNA damage and
repair. There is precedence for this. We have shown that
H. pylori OMVs induce DNA damage to AGS gastric
carcinoma cells, as determined by cytokinesis-block micro-
nuclei assay [26].
Another marker of DNA repair is the recruitment and
phosphorylation of the histone γH2Ax to the damaged
site. This provides a platform for the recruitment of DNA
repair enzymes that can be detected by immunofluores-
cence microscopy [54-56] and we hypothesised that we
would detect increased staining for γH2Ax in the nuclei of
Caco-2 cells exposed to OMVs. We found that occasional
Figure 4 E. coli OMVs induce reactive oxygen species generation and DNA damage. (A) DH5α and LF82 derived OMVs decrease cellular
GSH, indicating an increase in ROS. nd denotes not detected. (B) DH5α and LF82 derived OMVs are associated with the formation of mutagenic
8-oxo-dG adducts (green) in Caco-2 nuclei (blue). (C) OMVs induce DNA double strand breaks in Caco-2 cells as measured by Comet assay. (D)
OMVs induce the recruitment of γH2Ax histone (green) to sites of damaged nuclear DNA (blue). (E) Flow cytometric analysis of γH2Ax expression
during the G1 phase of the cell cycle of Cacco-2 cells. (A), (C) and (E), *, results are significantly different from untreated controls (p≤ 0.05).
ANOVA, followed by two-sided Dunnet’s post hoc test. Results are ± SEM of three independent experiments. (B) and (D), Immunofluorescence
microscopy images are from a single representative experiment. Original magnification = 40×, NA1.3 objective used, scale bar indicates 50 μm.
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cated by the punctate green nuclear staining in fluores-
cence micrographs (Figure 4D). This was expected as cells
often constitutively generate free radicals with resultant
low level DNA damage [57]. However, following exposure
to DH5α and LF82 OMVs, notably more cells displayed
the green nuclear staining demonstrating that there was
greater recruitment of γH2Ax to DSBs and therefore more
DNA damage (Figure 4D) and/or increased initiation of
DNA repair. These results were confirmed by quanti-
fication by flow cytometry of immunolabelled γH2Ax
stimulated and unstimulated Caco-2 cells (Figure 4E).In unstimulated cells, the level of γH2Ax expression was
85.68 +/- 36.07 (mean fluorescence intensity in arbitary
units), while DH5α OMV stimulated and LF82 OMV
stimulated Caco-2 cells had statistically significant in-
creases in γH2Ax expression (363.82 +/- 35.10, p = 0.029
and 332.54 +/- 109.56, 0.049 respectively, ANOVA fol-
lowed by Dunnett’s 2-sided post-hoc test). In contrast,
O157:H7 OMVs induce no significant increase in γH2Ax
expression detected either by immunofluorescence micros-
copy or flow cytomtery. These data concur with our earlier
observations regarding the increases in the incorporation
of BrdU and therefore DNA synthesis.
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cytopathological changes consistent with DNA
rereplication
When DNA repair fails, some cells escape cell cycle arrest
and enter an abnormal mitosis. This process is described
as rereplication and is characterised by significant changes
in cellular morphology. Affected cells become distended,
develop actin stress fibres due to improper cytokinesis,
and become micro- and multinucleate [58]. We stained
cells exposed to OMVs for 24, 48, and 72 hours for the
cytoskeletal proteins cytokeratin-18 and actin while coun-
terstaining with Hoechst 33342, in order to examine cellu-
lar and nuclear morphology (Figure 5A). Unstimulated
cells remained largely mononucleate with nuclei of a nor-
mal size, the cells did not grow in size, and there was noFigure 5 E. coli OMVs produce morphopathogenic changes to
Caco-2 cells consistent with endoreplication and can induce
aneuploidy. (A) Immunofluorescence labelling of actin (red),
cytokeratin 18 (green), and nuclei blue was used to show that OMVs
cause endoreplication in Caco-2 cells over time. Images are from a
single representative experiment. Original magnification = 20×, NA
0.50 objective used, scale bar indicates 50 μm. (B) OMVs (5 μg/ml)
are associated with the generation of aneuploidy in Caco-2 cells
exposed for 7 days to DH5α and O157:H7 OMVs, as measured using
flow cytometry of propidium iodide stained and RNase 1 treated cells.
*, results are significantly different from untreated controls (p≤ 0.05).
ANOVA, followed by two-sided Dunnet’s post hoc test. Results are ± SEM
of three independent experiments.evidence of actin stress fibres over the 3 day period. Also,
occasional cells were observed that exhibited micronuclei.
In contrast, cells exposed to OMVs displayed many of the
features associated with the induction of rereplication.
Cells were enlarged, becoming in some cases greater than
300 μm in diameter and additionally showed distended
(50 μm diameter) nuclei. Many cells were multinucleate,
had multiple micronuclei and developed actin stress fibres.
Collectively, these findings suggest that exposure of cells
to E. coli. OMVs results in the induction of rereplication.
OMVs induce aneuploidy
After rereplication and cells become tetraploid, p53 me-
diated signalling induces apoptosis in a process known
as mitotic catastrophe, thus deleting DNA damaged cells
from the population [59,60]. This has the purpose of
removing potential cancer progenitors from the popula-
tion. In cells with mutations in the p53 pathway, a fail-
ure of mitotic catastrophe to delete DNA damaged cells
can lead to chromosomal instability and aneuploidy in
subsequent generations of daughter cells, an important
mechanism of tumourigenesis [61,62]. To determine the
potential of OMVs to initiate aneuploidy, we stimulated
cells with 5 μg/ml OMVs for 168h. The samples were
then subjected to DNA content analysis by flow cytome-
try (Figure 5B). Aneuploid cells can be detected by mea-
surements of cells containing greater than > G2 DNA
content. Caco-2 are a chromosomally unstable cell line
and aneuploid, so we examined whether there was an in-
crease in the percentage of cells displaying an abnormal
DNA content, compared to unstimulated controls. After
168 hours, OMVs derived from O157:H7 bacteria had
increased the percentage of cells that contained > G2
compared to unstimulated controls (16.45% +/- 0.76 and
12.45% +/- 0.75, respectively, p = 0.049), as did DH5α
OMVs (16.48% +/- 1.01, p = 0.047). LF82 OMVs had no
effect on > G2 DNA content after 168 hours (14.87+/-
1.29, p = 0.259). No OMVs had any statistically signifi-
cant effect on the percentages of cells of sub G0, G0/1, S,
or G2 DNA content.
O157:H7 OMV induce G0/1G1 cell cycle arrest and loss of
aneuploid cells in chromosomally stable and p53 positive
LoVo cells
Caco-2 cells are commonly used in studies of intestinal
epithelia as they display many of the characteristics of
enterocytes that include the expression of digestive en-
zymes and apical surface microvilli. However, Caco-2
cells are chromosomally unstable and therefore normally
aneuploid. In addition, they also express a non-functional
truncated p53. Since p53 is involved in DNA damage
signalling and directs cells to either arrest at G0/1 to
undergo DNA repair, or undergo apoptosis, we considered
that our results from experiments using Caco-2 cells could
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whether E. coli OMVs could alter the DNA content and
cell cycle of chromosomally stable and p53 wild type LoVo
epithelial cells. We found that 4 day exposure to DH5α or
LF82-derived OMVs had no effect on the cell cycle or an-
euploidy of LoVo cells, but O157:H7 OMVs induced a
dose dependent G0/1 cell cycle arrest with a significant re-
duction in the number of G2/M cells (38.06 +/- 3.25% and
26.41 +/- 3.27% for control and 5μg/ml O157:H7 OMVs
respectively, p = 0.035) (Figure 6).
Discussion
This study was performed to determine if OMVs shed
from the surface of an avirulent, a putative pathogenic and
an overtly pathogenic strain of E. coli have the potential to
induce carcinogenesis in intestinal epithelial cells. By label-
ling the OMVs with the fluorescent dye DiO, we were able
to observe the internalisation of the OMVs into Caco-2
cells. We will perform further experiments to confirm the
stability of DiO-labelled OMVs at 4°C. We found that
OMVs from all three strains of E. coli examined were inter-
nalised into Caco-2 cells, and that two of the three strains
were capable of inducing oxidative stress. Intriguingly, the
pathogenic strain O157:H7 was the one strain in this study
that produced OMVs that did not induce oxidative stress.
DNA damage, including mutagenic changes and later an-
euploidy, was a consequence of exposing intestinal Caco-2
epithelial cells to E. coli OMVs, irrespective of strain, but
OMVs from the strains LF82 and O157:H7 also signifi-
cantly increased cell proliferation.Figure 6 O157:H7 E. coli induce cell cycle changes in LoVo cells. LoVo
cycle analysis. O157:H7 OMV induced a dose dependent G1 arrest. *, result
followed by two-sided Dunnet’s post hoc test. Results are ± SEM of three inPerhaps surprisingly, OMVs from E. coli DH5α, an
avirulent strain of E. coli, were capable of inducing free
radical formation that was associated with genotoxic
changes in cellular DNA, rereplication, and an increase in
the percentage of aneuploid cells. However, results of our
study are consistent with that of Koturbash et al [63], who
showed that DH5α could induce genotoxicity in murine
small intestine, liver, and spleen tissues, even after the
bacteria were heat-killed. Collectively, these findings em-
phasise the need to examine the genotoxic potential of mi-
croorganisms currently thought to be non-pathogenic.
Adherent-invasive E. coli strain LF82 is associated with
Crohn’s disease [36], which can lead to colon cancer
later in life [64,65]. Strain LF82 and other AIEC bacteria
are considered pathobionts, which are commensal bac-
teria that can lead to disease. Consistent with a possible
role for LF82 in carcinogenesis, we found that OMVs
derived from E. coli strain LF82 induced DNA damage,
8-oxo-dG adducts, DNA rereplication, and aneuploidy.
As AIEC can colonise the gut and hence can reside in
the intestine for considerable periods, the ability of their
OMVs to induce ROS and DNA damage suggest that
LF82 is, potentially, a significant risk for genotoxic dam-
age within the gut.
It is not known what components of DH5α and LF82
derived OMVs could cause genotoxicity in enterocyte-
like cells. We plan to perform a proteomics study to iden-
tify potential genotoxins.
Koturbash et al [63] also noted that heat-killed E. coli
O157:H7 was genotoxic and our results support this.cells were exposed to OMVs for 4 days, before being subjected to cell
s are significantly different from untreated controls (p≤ 0.05). ANOVA,
dependent experiments.
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ation, as indicated by GSH assays, nor did they induce
the formation of 8-oxo-dG adducts, but they did cause
the formation of double strand breaks in Caco-2 cell
DNA. OMVs from strain O157:H7 contain cytolethal
distending toxin (CDT) [66]. CDT has significant struc-
tural and functional homology to eukaryotic Dnase I
[51] and is capable of cutting through DNA strands and
therefore generating double strand breaks. This results
in significant cell distension, typical of rereplication, and
eventually cell death through mitotic catastrophe [50].
However, instead of dying, the O157:H7 OMV-treated
cells in our study continued to proliferate, had fewer
cells than controls at G0/1 of the cell cycle, and a greater
number of aneuploid cells. These data indicate that
DNA damaged cells are not depleted from the popula-
tion, remain aneuploid and could be carcinogenic. We
consider that this may relate to the presence of other
toxins produced by O157:H7, but this remains to be
confirmed. We will conduct further proteomic analyses
of O157:H7 OMVs to identify these toxins.
The effects of O157:H7 OMVs appeared to be dependent
on the p53 status of the cell line used. In p53 mutant
Caco-2 cells, these OMVs increased the numbers of aneu-
ploid cells. In contrast, the number of aneuploid cells was
decreased in p53 wild type LoVo cells following exposure
to O157:H7 OMVs. There was a small increase in the
number of sub-G0/1 cells, compared to unexposed LoVo
cells, suggesting the induction of apoptosis (although this
requires confirmation). Also, dose dependent G0/1, and to
a lesser extent S phase cell cycle arrest was observed.
O157:H7 bacteria express Shiga toxins and these are found
in their OMVs [32]. Shiga-1 toxin (Stx1) induces p53 medi-
ated cell toxicity [67]. This toxin can also cause S cell cycle
arrest in HCT116 cells [68], a line that is also p53 wild type
and chromosomally stable. Our results, which are consist-
ent with these findings, indicate that O157:H7 OMV can
induce cell cycle arrest, leading to eventual cell death and
removal of aneuploid cells in p53 wild type cells. We will
perform additional experiments that involve the knocking
in of functional p53 into Caco-2 cells and knocking out of
p53 in LoVo cells to further confirm our findings.
Recently, the product of the pks pathogenicity island
colibactin has been found to be genotoxic [69] and
prevalent in many pathogenic and commensal B2 E. coli
[70]. It is of note that none of the three strains of E. coli
examined in this study possess this pathogenicity island
[71-73], and therefore the genotoxicity of their OMVs
cannot be attributed to colibactin.
Genotoxicity and alterations in cell growth are signifi-
cant contributors to carcinogenesis. We have shown that
each of three E. coli OMVs tested in this study were gen-
otoxic and two were capable of inducing alterations in
the rate of cell proliferation in a time-dependent manner.However, these data do not indisputably show that these
OMVs are carcinogenic. Further studies, for example in
the APC min -/- mouse model [74], are required to con-
firm this.
Conclusion
In summary, we have shown that E. coli-derived OMVs
are readily internalised into Caco-2 cells, where they are
potentially capable of inducing oxidative stress, leading
to DNA damage, rereplication and aneuploidy in suscep-
tible cells. In addition, O157:H7 derived OMVs gener-
ated aneuploid cells typical of those with chromosomal




DMEM, MEM non-essential amino acids, 100× penicillin/
streptomycin, foetal bovine serum, Dulbecco’s phosphate-
buffered saline (D-PBS), 0.25% w/v trypsin-EDTA,
Vybrant™ DiO (3,3′-dioctadecyloxacarbocyanine perchlo-
rate), Hoechst 33342, TRITC-phalloidin, SlowFade anti-
fade reagent, and Alexa 488 and Alexa 594 conjugates
were all obtained from Life Technologies (Mulgrave,
Victoria, Australia). Vivaspin 500 ultrafiltration were from
Sartorius Stedim Biotech GmbH (Goettingen, Germany).
Anti-8-oxo-2′-deoxyguanosine (8-oxo-dG) antibody was
bought from Trevigen, Inc. (Gaithersburg, MD, United
States). Glutathione Assay Kit was purchased from
Cayman Biosciences (Sapphire Biosciences, Auckland,
New Zealand). Cell Proliferation ELISA, BrdU (colormetric)
was obtained from Roche Diagnostics GmbH (Mannheim,
Germany). All other reagents were bought from Sigma
(Auckland, New Zealand).
Bacterial strains
Three E. coli strains were used in this study. A
non-pathogenic E. coli laboratory strain DH5α [29],
adherent-invasive E. coli (AIEC) strain LF82 [75] and
enterohaemolytic E. coli (EHEC) (CDC strain G5244) sero-
type O157:H7 [New Zealand Reference Culture Collection]
[31]. LF82 was kindly provided by Dr. Darfeuille-Michaud
(Université d'Auvergne, Clermont-Ferrand, France).
Harvesting and labeling of OMVs
Outer membrane vesicles were harvested as previously
described [25]. Briefly, E. coli were grown overnight in
Luria Bertani (LB) broth at 37°C with constant rotation
(120 rpm). Bacteria were removed by two centrifugations
(10 000 × g, 15 minutes, 4°C) and the final supernatants
ultracentrifuged (150 000 × g, 3 hours, 4°C) to recover
OMVs. The resultant OMV pellet was washed twice
times in 0.15 M pH 8.2 Tris-buffered saline (TBS) and
filtered through a 0.45 μm syringe filter (to remove any
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once after recovery then, to standardize labeling, were
suspended in 1 ml TBS/50 mg OMV pellet. OMVs were
labeled with 1% Vybrant™ DiO by incubation for 20 mi-
nutes at 37°C. Free dye was removed by three washes
with 300 000 Da cutoff Vivaspin 500 ultrafiltration units.
Briefly, OMVs were added to the units with 500 μl of
TBS, and then centrifuged at 14 000× g for 25 minutes.
The retentate (containing the OMVs) was diluted with
500 μl of TBS and the process repeated twice more.
After before being assayed for protein content using a
modification of the Lowry assay [76], unlabeled OMVs
were stored at -20°C until required whereas labelled
OMVs were stored at 4°C for up to six weeks.
Transmission electron microscopy of OMVs
Transmission electron microscopy (TEM) was used
to determine the quality of the OMV preparation.
Samples of OMVs were placed on hydrophilic EM grids
and stained with 1% v/v phosphotungstic acid, pH 6.8 and
viewed with a Philips CM100 transmission electron micro-
scope (Philips/FEI Eindhoven, The Netherlands) operating
at 100kV. Images were captured using a MegaView 3 cam-
era (Soft Imaging System GmbH, Münster, Germany).
Cell culture
The Caco-2 and LoVo cells were routinely cultured in
Dulbecco’s Modified Eagles Medium with Glutamax I,
4500 mg/l glucose and pyridoxal, supplemented with
10% v/v foetal calf serum, 1% v/v MEM non-essential
amino acids, 50 units/ml penicillin and 50 μg/ml strepto-
mycin. The cells were incubated at 37°C, in 5% CO2 and
Caco-2 cells passaged 1:10 every 7 days, while LoVo cells
were passaged 1:10 every 5 days. Cells (1 × 105 per ml)
were routinely plated and cultured for 24 hours (to allow
cells to attach) before the addition of OMVs.
Uptake of OMVs by Caco-2 cells
Caco-2 cells plated overnight on ethanol sterilised poly-
lysine coated coverslips in 6-well tissue culture plates
were then incubated with labelled OMVs (5 μg/ml)
for 24 hours. The cells were washed three times with
D-PBS, and then fixed in 10% v/v neutral buffered forma-
lin for 15 minutes, before permeabilisation with 0.1% v/v
Triton X-100 in D-PBS for 15 minutes. Non-specific
binding was blocked with 5% w/v bovine serum albumin
in D-PBS for 1hour then stained with TRITC-phalloidin
for 1 hour, before counterstaining with 1 μg/ml Hoescht
33342 for 15 minutes. The coverslips were then mounted
in ProLong Gold mounting medium. The slides were
imaged with a Zeiss Imager Z1 microscope, 40× NA
1.3 objective, Zeiss Apotome structured illumination sys-
tem and Zeiss MRc camera. Image stacks were taken at
0.28 μm intervals. Images were adjusted for presentation(brightness, contrast and 3-dimensional reconstruction)
with NIH ImageJ.
Effect of OMVs on cell viability and proliferation
The ability of the OMVs to affect the long-term viability
and proliferation of Caco-2 cells was assessed by Trypan
blue exclusion. Caco-2 cells plated into 24-well plates
were exposed to 5 μg/ml OMVs for up to 168 hours. At
two day intervals, the cells were trypsinised, stained with
0.25% w/v Trypan blue, and counted with a haemocyt-
ometer. The Mean Proliferative Index (MPI) at any given
point was calculated as:
MPI ¼ Number of cells treated with OMVs in each well=
Number of control cells in each well
 100:
The dose-dependent effects of OMVs on the prolifera-
tion of Caco-2 cells cultured for shorter periods of time
were also determined using the MTT and BrdU assays.
The MTT assay is based on the mitochondrial reduction
of tetrazolium to formazan, a reaction that is considered
directly proportional to viable cell numbers. In contrast,
the BrdU assay determines incorporation of the thymi-
dine analogue BrdU into DNA during S-phase of the cell
cycle to measure proliferation. Caco-2 cells (1 × 104)
were plated (in 100 μl of media) into the wells of a 96-
well plate and incubated for 24 hours at 37°C before the
addition of E. coli OMVs at concentrations between 0.5
ng/ml and 5 μg/ml. After incubation at 37°C for a fur-
ther 24 hours, 20 μl of 2.5 mg/ml MTT was added to
each well and the plate incubated for 5 hours at 37°C.
The media was then discarded and 100 μl isopropyl al-
cohol containing 0.04 M HCl added to each wells. The
absorbance of the wells was read at 490 nm with correc-
tion at 650 nm. For the BrdU assay, cells were plated
and treated as described for the MTT assay and then the
degree of BrdU incorporation was determined by Roche
Cell Proliferation ELISA, BrdU (Colorimetric), according
to manufacturer’s instructions.
Fluorescence microscopy of the cytopathological effects
of OMVs
Caco-2 cells (100 000) plated overnight on ethanol steri-
lised coverslips in tissue culture plates were incubated
with labelled OMVs (5 μg/ml) for the times indicated.
The cells were fixed with 10% neutral buffered formalin
for 15 minutes, and then permeabilised with 0.1% v/v
Triton X-100 for 15 minutes. Potential non-specific bind-
ing sites were blocked by incubating the coverslips for
1 hour 37°C in 5% w/v bovine serum albumin in D-PBS
(blocking buffer). The cells were probed with 1 μg/ml
mouse anti-cytokeratin antibody in blocking buffer for
1 hour at 37°C, washed 3 times with D-PBS, then
probed again with 1/500 dilution of anti-mouse Alexa 488
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The cytoskeletal protein actin was stained with TRITC-
phalloidin for 1 hour. After washing, the cells were coun-
terstained with 1 μg/ml Hoechst 33342, mounted with
SlowFade mounting media and photographed.
Measurement of oxidatative stress by glutathione assay
The potential of OMVs to induce oxidative stress in
Caco-2 cells was determined by measurement of glutathi-
one (GSH). Caco-2 cells (100 000) were plated overnight in
24-well tissue culture plates and then exposed to 5 μg/ml
of OMVs, or 300 μM H2O2 (positive control) for 24 hours.
The cells were lysed by freeze thawing from -80°C three
times before assay with Cayman Glutathione Assay Kit,
used according to manufacturer’s instructions.
Immunofluorescence microscopy of mutagenic 8-oxo-dG
adducts in cells exposed to OMVs
The generation of free radicals in cells can lead to the
development of mutagenic 8-oxo-dG adducts in DNA.
Immunofluorescence microscopy was used to identify
the presence of these lesions in OMV exposed Caco-2
cells. For the detection of 8-oxo-dG in cell nuclei, we
followed the primary antibody manufacturer’s instruc-
tions. Briefly, the cells were washed 3 times with D-PBS,
and then fixed with -30°C 100% v/v ethanol for 20 mi-
nutes. After treatment with 0.05N HCl for 5 minutes on
ice followed by three washes in D-PBS, the cells were
exposed to 100 μg/ml RNAse in 150 mM NaCl, 15 mM
sodium citrate for 1 hour at 37°C before being washed
sequentially in D-PBS, 35%, 50%, and 75% ethanol for 3
minutes each. DNA was denatured by addition of 0.15 N
NaOH in 70% v/v ethanol for 4 minutes, followed by
two washes in D-PBS after which the cells were exposed
sequentially to 70% ethanol containing 4% v/v formalde-
hyde, 50% and 35% ethanol, then D-PBS for 2 minutes
each. After incubation in 5 μg/ml proteinase K in 20
mM Tris and 1 mM EDTA, pH 7.5 (10 minutes each),
the cells were washed 3 times in D-PBS before immuno-
labeling (as above) with anti-8-oxo-dG antibody and
Alexa 488 and counterstaining with Hoechst 33342.
Alkaline single-cell gel electrophoresis (Comet assay) of
DNA damage in OMV-exposed Caco-2 cells
DNA damage is a feature of carcinogenesis. We used
the alkaline single-cell gel electrophoresis (Comet) assay
to determine the degree of double-strand DNA breaks
(DSBs) induced by OMVs and hence their genotoxicity.
Clear glass slides were coated twice with 1% w/v normal
melting point agarose then dried in a 37°C oven. Adherent
Caco-2 cells exposed to either OMVs (concentrations be-
tween 0.005 and 5 μg/ml) or 300 μM H2O2 (positive con-
trol) for 24 hours were trypsinised, washed twice in D-PBS
and added to 70 μl 1% low melting point agarose, whichwas then spread on the coated slides. The agarose-
suspended cells were covered with a 22 × 22 mm No1
coverslip and the slides left at 4°C for approximately 30
minutes to allow the agarose the set before the cells were
lysed overnight at 4°C in lysis buffer (2.5 M NaCl, 0.1 M
EDTA, 10 mM Tris, 1% v/v Triton X-100, pH 10). The
slides were transferred to a BioRad horizontal electrophor-
esis tank containing electrophoresis buffer (0.3 M NaOH,
1 mM EDTA) and left for 40 minutes to equilibrate before
being electrophoresed for 25 minutes at 0.5V/cm. After
three washes in neutralisation buffer (0.4M Tris pH 7.5)
the cells were stained with 0.5 μg/ml Hoechst 33342. The
slides were imaged with a Zeiss Imager Z1 with 20× NA
0.5 objective and Zeiss MRc camera. The percentage
of DNA in each comet tail (linearly proportional to
DNA break frequency) of at least 100 cells per sample was
measured with Comet Score IV software (TriTek Corp,
VA, USA).
Detection of the DNA damage response histone γH2Ax in
cell nuclei
The localisation of phosphorylated histone γH2Ax, which
is recruited to sites of DNA damage, was determined in
OMV-exposed Caco-2 cells using immunofluorescence mi-
croscopy. The cells were treated as described for detection
of the cytopathological changes, except mouse-anti-γH2Ax
antibody (1 μg/ml) replaced the anti-cytokeratin antibody
and the phalloidin staining was omitted.
For quantification of the presence of γH2Ax in the nuclei
of OMV exposed cells flow cytometry was used. As γH2Ax
can be expressed during the S and G2/M phases of the cell
cycle due to DNA replication, only γH2Ax found in G1
was used for quantifiaction as this represents expression
due to DNA damage [77]. Caco-2 cells were plated into
24-well tissue culture plates were exposed to 5 μg/ml
OMVs for 7 days, then washed in culture medium to re-
move unbound OMVs. The cells were trypsinised, then
fixed in ice-cold ethanol, and stored at -30°C until analysis.
The fixed cells were washed three times with D-PBS, the
treated with 200 μg/ml RNAse, and stained with 10 μg/ml
propidium iodide for at least 30 minutes at room tem-
perature. The cells were then blocked in 5% BSA for 1
hour at 37°C, then incubated in 1 μg/ml anti-gH2Ax anti-
body for 1 hour at 37C. After washing three times in PBS,
1/500 anti-mouse Alexa 488 was added to the samples for
1 hour at 37°C. The cells were washed then analysed using
a Beckman Coulter Cytomics FC500 flow cytometer.
γH2Ax positive cells were measured from data gated to the
G1 phase of the cells cycle Weasel v3.0 software (Walter
and Elizabeth Hall Institute, Melbourne, Australia).
Flow cytometry of Caco-2 and LoVo cell DNA content
A feature of carcinogenesis is the development of chromo-
somal instability, leading to the generation of cells with
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try was used to assay these changes in OMV exposed cells.
As Caco-2 cells are karyotypically unstable, we also used
the more stable LoVo cells to investigate the effect of
E. coli OMVs on cellular DNA content. Cells (Caco-2 or
LoVo, 100 000) were plated into 24-well tissue culture
plates were exposed to 5 μg/ml OMVs for 7 days,
then washed in culture medium to remove unbound
OMVs. The cells were trypsinised, then fixed in ice-cold
ethanol, and stored at -30°C until analysis. The fixed cells
were washed three times with D-PBS, the treated with
200 μg/ml RNAse, and stained with 10 μg/ml propidium
iodide for at least 30 minutes at room temperature. Fluor-
escence measurements were made using a Beckman
Coulter Cytomics FC500 flow cytometer. Cell cycle ana-
lysis and the analysis of aneuploidy (cells with greater than
G2/M content) was performed with the cell cycle meas-
urement tools of Weasel v3.0 software that deconvolves
flow histograms. Gaussian models were fitted to the histo-
gram data to obtain the percentage of cells with sub G1,
G0/1, S, G2/M and >G2/M DNA content. Typically, the
results were obtained after convergence at 700 iterations.Statistical analysis
Data are expressed as mean +/- standard error of the mean
(SEM) of three independent experiments. Student’s t-tests
and analysis of variance (ANOVA) with Dunnett’s post hoc
test was used as tests of statistical significance, as indicated
in the Results. P values less than or equal to 0.05 were con-
sidered to be significant. Analyses were performed with
IBM SPSS versions 17, 19 and 22.
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